| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/13/2005 | EP1553175A1 Cephalosporin C acylase mutants |
| 07/13/2005 | EP1553174A2 Enzymes and detergent compositons |
| 07/13/2005 | EP1553173A2 Enzymes and detergent compositions |
| 07/13/2005 | EP1553172A1 Thermostable ribonuclease |
| 07/13/2005 | EP1553170A1 Novel carbonyl reductase, gene thereof and method of using the same |
| 07/13/2005 | EP1553168A2 Methods for selectively stimulating proliferation of T cells |
| 07/13/2005 | EP1552887A2 Device and method for printing biomolecules onto substrate using electrohydrodynamic effect |
| 07/13/2005 | EP1552852A1 Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit |
| 07/13/2005 | EP1552740A1 Chimeric murine model comprising human hepatocytes - use for screening compounds |
| 07/13/2005 | EP1552310A2 Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylyltransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases |
| 07/13/2005 | EP1552308A1 Demethylated and/or oxidized membrane dna and use thereof in the diagnostic of autoimmune diseases |
| 07/13/2005 | EP1552305A2 Polypeptide immobilization |
| 07/13/2005 | EP1552298A2 Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs |
| 07/13/2005 | EP1552294A1 Systems and methods for constructing genomic-based phenotypic models |
| 07/13/2005 | EP1552024A2 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 07/13/2005 | EP1552023A2 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 07/13/2005 | EP1552022A2 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis a viral nucleic acid |
| 07/13/2005 | EP1552018A2 Methods and compositions relating to gene silencing |
| 07/13/2005 | EP1552013A1 Microfluidic device including purification column with excess diluent, and method |
| 07/13/2005 | EP1552009A2 Method for identifying cellular growth inhibitors |
| 07/13/2005 | EP1552008A1 Microparticle based signal amplification for the detection of analytes |
| 07/13/2005 | EP1552005A1 Apparatus and method for isolating a nucleic acid from a sample |
| 07/13/2005 | EP1552003A1 Methods to assess quality of microarrays |
| 07/13/2005 | EP1552002A2 Aptamer-toxin molecules and methods for using same |
| 07/13/2005 | EP1551998A2 Method for diagnosing non-small cell lung cancers |
| 07/13/2005 | EP1551993A1 A method for screening for an antimicrobial polypeptide |
| 07/13/2005 | EP1551990A2 Diagnosis and treatment of chemoresistant tumors |
| 07/13/2005 | EP1551988A2 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 07/13/2005 | EP1551986A2 Polynucleotide synthesis and labeling by kinetic sampling ligation |
| 07/13/2005 | EP1551985A2 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins |
| 07/13/2005 | EP1551984A1 A role in lignification and growth for plant phenylcoumaran benzylic ether reductase |
| 07/13/2005 | EP1551983A2 Identification of e2f target genes and uses thereof |
| 07/13/2005 | EP1551982A1 Transcriptional control element, chimeric constructs and uses therefor |
| 07/13/2005 | EP1551981A1 Expressional enhancers from viruses |
| 07/13/2005 | EP1551980A2 Stabilized naked dna compositions |
| 07/13/2005 | EP1551976A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 07/13/2005 | EP1551975A2 Polypeptides involved in spiramycin biosynthesis, nucleotide sequences encoding said polypeptides and uses thereof |
| 07/13/2005 | EP1551974A1 Vector system |
| 07/13/2005 | EP1551973A1 New gdf-9 and gdf-9b (bmp-15) sequences for altering mammalian ovarian function and ovulation rate |
| 07/13/2005 | EP1551972A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 07/13/2005 | EP1551971A2 Sirna mediated gene silencing in transgenic animals |
| 07/13/2005 | EP1551970A2 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 07/13/2005 | EP1551969A1 A method of altering levels of plasmids |
| 07/13/2005 | EP1551968A2 Pathogen-responsive genes, promoters, regulatory elements, and methods of use for same |
| 07/13/2005 | EP1551967A2 Compositions and methods for the modulation of gene expression in plants |
| 07/13/2005 | EP1551966A2 Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing |
| 07/13/2005 | EP1551964A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 07/13/2005 | EP1551963A1 Improved immunotherapy |
| 07/13/2005 | EP1551959A2 Modulators of chloride intracellular channel 1 protein signaling |
| 07/13/2005 | EP1551957A2 Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same |
| 07/13/2005 | EP1551955A2 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 07/13/2005 | EP1551951A1 Genetically modified microorganisms, plasmid and fermentation process with the presence of flocculation regulated by medium changes |
| 07/13/2005 | EP1551877A2 Taci antibodies and uses thereof |
| 07/13/2005 | EP1551874A2 Alpha macroglobulin protein family members |
| 07/13/2005 | EP1551872A2 G-protein coupled receptors |
| 07/13/2005 | EP1551868A2 Factor involved in metastasis and uses thereof |
| 07/13/2005 | EP1551867A2 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
| 07/13/2005 | EP1551861A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/13/2005 | EP1551859A2 Aav itr-mediated modulation |
| 07/13/2005 | EP1551857A2 A robust, inducible cardiac preferred expression system for transgenesis |
| 07/13/2005 | EP1551627A2 Method and composition for forming a protective coating on an assay substrate and substrate produced by the same |
| 07/13/2005 | EP1551453A2 Specificity grafting of a murine antibody onto a human framework |
| 07/13/2005 | EP1551451A2 Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry |
| 07/13/2005 | EP1551440A2 Uses of human zven proteins and polynucleotides |
| 07/13/2005 | EP1551437A2 Methods and compositions for detecting cancers |
| 07/13/2005 | EP1551434A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/13/2005 | EP1551424A1 Treatment of neurological disorders by dsrna adminitration |
| 07/13/2005 | EP1551222A2 Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mammal obtained by implementing said method and said mammal's progeny |
| 07/13/2005 | EP1551221A2 Nucleic acid compositions for stimulating immune responses |
| 07/13/2005 | EP1551218A2 Wheat plants having increased resistance to imidazolinone herbicides |
| 07/13/2005 | EP1476537B1 Container with at least one electrode |
| 07/13/2005 | EP1409669A4 Root specific, stimulant inducible promoter and its use |
| 07/13/2005 | EP1390710A4 Amplification and detection of $i(mycoplasma pneumoniae) |
| 07/13/2005 | EP1360327A4 Method for identifying genes regulating desired cell phenotypes |
| 07/13/2005 | EP1266039B1 Method and kit for the screening, the detection and/or the quantification of transcriptional factors |
| 07/13/2005 | EP0804548B1 Patched genes and their use |
| 07/13/2005 | EP0698099B1 Method for the culture in vitro of different stages of tissue parasites |
| 07/13/2005 | EP0681431B1 Production of human recombinant collagen in the milk of transgenic animals |
| 07/13/2005 | EP0394296B2 Assay of a body fluid for measuring bone resorption |
| 07/13/2005 | CN1639569A Methods and compositions for inducing an immune response |
| 07/13/2005 | CN1639358A Multiple virus replicon culture systems |
| 07/13/2005 | CN1639357A Method for detecting human papillomarvirus mRNA |
| 07/13/2005 | CN1639356A Method for labelling and fragmenting DNA |
| 07/13/2005 | CN1639355A Double and triple readout assay systems |
| 07/13/2005 | CN1639353A Method for producing riboflavin |
| 07/13/2005 | CN1639352A Amplifying repetitive nucleic acid sequences |
| 07/13/2005 | CN1639350A Amino acid-producing bacteria and a process for preparing L-amino acids |
| 07/13/2005 | CN1639349A Microorganisms and processes for enhanced production of pantothenate |
| 07/13/2005 | CN1639347A Process for producing levodione |
| 07/13/2005 | CN1639345A LIS promoter for expression of transgenes in floral tissues |
| 07/13/2005 | CN1639344A A method of selectively producing male or female sterile plants |
| 07/13/2005 | CN1639343A Method for detection of leptin receptor ligands |
| 07/13/2005 | CN1639342A Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 07/13/2005 | CN1639341A Process for producing L-threonine with the use of bacterium belonging to the genus escherichia |
| 07/13/2005 | CN1639340A Method of controlling ethanol production |
| 07/13/2005 | CN1639339A Fermentation process |
| 07/13/2005 | CN1639338A Modified Cry3A toxins and nucleic acid sequences coding therefor |
| 07/13/2005 | CN1639337A Protein or polypeptide having lachrymator synthase activity, DNA encoding the protein or the polypeptide, process for producing protein or polypeptide having lachrymator synthase activity using the DN |
| 07/13/2005 | CN1639336A Method of separation using aromatic thioether ligands |
| 07/13/2005 | CN1639334A Novel method of highly sensitive nucleic acid analysis |